Edenwell Therapeutics Private Limited, established in 2017, is a distinguished Life Sciences Organization specializing in the development of specialty drugs and provision of comprehensive clinical research services. Committed to advancing healthcare, Edenwell actively supports clinical trials spanning from Phase I to Phase III and extends its services beyond product registration and commercialization. These include Phase IV regulatory studies and Post Marketing Studies (PMS).  The organization excels in a broad spectrum of offerings, encompassing clinical operations, project management, site feasibility, end to end regulatory services, data management and medical writing services.